NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
0 hedge funds and large institutions have $0 invested in NeuroMetrix, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.
100% less funds holding
Funds holding: 14 → 0 (-14)
100% less capital invested
Capital invested by funds: $600K → $0 (-$600K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 14
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$117K |
| 2 |
GS
GTS Securities
New York
|
-$111K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$87.1K |
| 4 |
DAM
Deltec Asset Management
New York
|
-$81K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$67.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| – | -$117K | -26,385 | Closed |
|
|
GS
2
GTS Securities
New York
| – | -$111K | -25,000 | Closed |
|
|
3
Citadel Advisors
Miami,
Florida
| – | -$87.1K | -19,610 | Closed |
|
|
DAM
4
Deltec Asset Management
New York
| – | -$81K | -18,318 | Closed |
|
|
5
Vanguard Group
Malvern,
Pennsylvania
| – | -$67.2K | -15,124 | Closed |
|
6
Geode Capital Management
Boston,
Massachusetts
| – | -$57K | -12,834 | Closed |
|
7
Mariner
Overland Park,
Kansas
| – | -$44.6K | -10,082 | Closed |
|
8
BlackRock
New York
| – | -$20.8K | -4,696 | Closed |
|
9
UBS Group
Zurich,
Switzerland
| – | -$8.35K | -1,889 | Closed |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| – | -$3.99K | -902 | Closed |
|
|
ACM
11
Accent Capital Management
Centerville,
Ohio
| – | -$1.33K | -300 | Closed |
|
12
Osaic Holdings
Scottsdale,
Arizona
| – | -$972 | -220 | Closed |
|
13
Bank of America
Charlotte,
North Carolina
| – | -$79 | -18 | Closed |
|
|
HI
14
Harbour Investments
Madison,
Wisconsin
| – | -$49 | -11 | Closed |
|
NURO Hedge Fund Activity: Q2 2025 in Review
0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2025, worth a combined $0 — down 100% from $600K a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of NURO and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Renaissance Technologies, exiting entirely with an estimated $117K sold.
- 0 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2025, down from 14 in Q1 2025.
- Funds reported $0 of NeuroMetrix, Inc. Common Stock stock for Q2 2025, down 100% quarter-over-quarter.
- 0 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2025 and 14 closed out, a net change of -14 holders.
- The largest NeuroMetrix, Inc. Common Stock seller in Q2 2025 was Renaissance Technologies, an estimated $117K sold.
Based on aggregated 13F filings for Q2 2025.